Is CME a good stock to buy?
CME Group Inc. · end-of-day data as of Nov 13, 2026
- ConsensusBuy · 17
- Trendbullish
- MAs4 of 4
- MACD0.58
- Sector▲ -1.8%
- Earnings in82d
- P/E26.1x
- Support-2.3%
- Off 52w high-3.4%
- Volume0.8x
- Bollingerupper half
- News0.00
- FCF yield+3.8%
- 52w range$218–$329
- ATR+2.1%
- Off ATH-3.4%
- PT$310.20 -2.4%
- P/E vs own+16.1%
- P/E vs sector+79.6%
- Insiders-$9.64M
- RSI72
Updates with the 15-min delayed price. Not a forecast or investment advice.
Is CME Group a good stock to buy?
CME Group is strong on 4 of the 4 questions about the business. The price is about usual: 26.1 times its earnings, near its 3-year median of 24.2 (Nov 13, 2026). pretickt does not say whether to buy or sell.
CME sales growth revenue growth
+9%a year, for the last 3 yearsCME Group's sales grew 9% a year for 3 years, to $6.52B in fiscal 2025.
CME analysts' forecast revenue estimates
+9%the sales they expect next fiscal year, on the lastAnalysts expect CME Group's sales to grow 9% to $7.09B in fiscal 2026 (12 analysts).
CME competitors
pretickt analysis+9%its sales in 12 months, on a year before
CME Group's sales grew 9% in the 12 months to Sep 30, 2026, faster than S&P Global (+6%) and Intercontinental Exchange (+5%), as fast as Moody's (+9%), slower than Nasdaq (+12%).
CME sales by business revenue by segment
81%of its sales from clearing and transaction feesclearing and transaction fees brought CME Group 81% of its sales in fiscal 2025; MarketData 12%.
CME margin after costs profit margin
66%of sales left after running the businessCME Group's operating margin was 66% in the 12 months to Sep 30, 2026, against 60% in fiscal 2022.
CME earnings vs estimates
7 of 8quarters above the analysts' estimateCME Group beat the analysts' profit estimate in 7 of its last 8 quarters, the latest on Oct 21, 2026.
CME insider selling
-$34.6Msold, net, by its executives in 12 monthsCME Group's executives and directors sold a net $34.6M of shares in the 12 months to Nov 13, 2026 ($35.27M sold, $667K bought).
CME number of employees
+3%more people in a yearCME Group had 3,875 employees at the end of fiscal 2025, 3% more than a year before.
CME CEO pay
$23.95Mfor fiscal 2024, 56% of it in stock and optionsCME Group paid its CEO $23.95M for fiscal 2024, 56% of it in stock and options.
CME in past recessions
pretickt analysis0%its sales in the worst oneCME Group's sales did not fall in any of the last 2 US recessions (2008–09 and 2020).
CME price vs profit P/E ratio
26.1×a year's earningsCME Group's P/E ratio is 26.1 (Nov 13, 2026), near its 3-year median of 24.2.
CME price vs assets price to book
4.3×times what its assets are worth on paperCME Group trades at 4.3 times its book value (Nov 13, 2026); its competitors' median is 6.0.
CME price vs competitors
pretickt analysis26.1×a year's earnings, against its competitorsInvestors pay 26.1 times CME Group's earnings (Nov 13, 2026), more than for Intercontinental Exchange (24.4), less than for Moody's (31.0), Nasdaq (29.6) and S&P Global (28.2).
CME analysts' target price target
-2%to their average targetAnalysts' average price target for CME Group is $310, 2% below the Nov 13, 2026 close of $317.97.
CME analyst ratings, 90 days
pretickt analysisDeutsche Bankdowngrade JP Morganupgrade
In the 90 days to Nov 13, 2026, JP Morgan upgraded CME Group; Deutsche Bank downgraded it.
CME growth priced in fair value
pretickt analysis+11%a year, for ten years, to be worth the priceAt $317.97 a share, CME Group's free cash flow must grow about 11% a year for ten years to be worth the price (Nov 13, 2026).
What is CME Group's P/E ratio?
CME Group's P/E ratio is 26.1 (Nov 13, 2026), near its 3-year median of 24.2. Investors pay 26.1 times CME Group's earnings (Nov 13, 2026), more than for Intercontinental Exchange (24.4), less than for Moody's (31.0), Nasdaq (29.6) and S&P Global (28.2).
Who are CME Group's biggest competitors?
pretickt compares CME Group with Intercontinental Exchange, S&P Global, Moody's and Nasdaq. CME Group's sales grew 9% in the 12 months to Sep 30, 2026, faster than S&P Global (+6%) and Intercontinental Exchange (+5%), as fast as Moody's (+9%), slower than Nasdaq (+12%).
Is CME Group profitable?
CME Group's operating margin was 66% in the 12 months to Sep 30, 2026, against 60% in fiscal 2022.
Are insiders selling CME Group stock?
CME Group's executives and directors sold a net $34.6M of shares in the 12 months to Nov 13, 2026 ($35.27M sold, $667K bought).
How does CME Group make money?
clearing and transaction fees brought CME Group 81% of its sales in fiscal 2025; MarketData 12%.
How many employees does CME Group have?
CME Group had 3,875 employees at the end of fiscal 2025, 3% more than a year before.
From the companies' statements (FMP), their filings read by pretickt, the analysts and the insiders, as of Nov 13, 2026. Each card says what a fact means for its question, never what to do with the stock: for information only, not investment advice.